The main task of the nomination committee is to present candidates for the Board of Directors, Chairman of the Board and to decide their fees. The nomination committee also presents proposals to the Annual General Meeting of possible remuneration for committee work and remuneration of external auditor. The nomination committee’s proposal is made public in connection to the call to the Annual General Meeting at the latest. The nomination committee’s mandate extends to when the next nomination has been announced.
At the Annual General Meeting of 2016 the following criteria for the nomination committee were established:
• One member shall be the Chairman of the Board.
• Two members appointed by the two major shareholders in Oasmia Pharmaceutical AB (publ) on September 30, 2016.
• The nomination committee elects its chairman among its members. The Chairman of the Board may not be the chairman of the nomination committee.
The nomination committee shall remain in office until a new committee is appointed. If a member leaves the committee before the assignment is completed, the remaining members shall appoint a substitute.
Shareholders who wishes to propose candidates for election to the Board can address Oasmia’s Chairman by e-mail: email@example.com
Before the Annual General Meeting 2017 the nomination committee consists of Julian Aleksov, Bo Cederstrand and Per Arwidsson.